Why choose Bionet
BIONETCorp. was established in 1999.
Serves more than 50% of newborns and 88% of reproductive medicine centers in Taiwan
while expanding services to 17 countries oversea meeting the health needs of more than 1.4 million customers at different stages in life.
In 2007, BIONET successfully completed initial public offering (IPO).
BIONET has received matching inquiries through the database for more than one thousand times from
over 30 different countries and released more than 360 stem cell units for cellular therapies throughout the world.
Key Services and Offerings
1. Customized Exosome Services(My Exosome): Amniotic fluid exosome(AF exosome), Cord blood exosome(CB exosome), Platelet-rich exosome(PRE), Mesenchymal stem cell-derived exosome.
2. Hematopoietic Stem Cell Storage and Applications: Cord blood and Adult peripheral blood stem cell banking.
3. Mesenchymal Stem Cell Storage and Applications: Cord tissue, Adipose tissue, and Dental pulp stem cell banking.
4. Immune Cell Storage and Applications: NK cell and CIK cell banking and therapies.
5. Non-Invasive Prenatal Chromosomal Testing (NIPT)
名人心得分享
一般存戶分享
一般存戶分享
醫護心得分享
Video
【BIONET Therapeutics】 AI-Driven, Scalable Exosome Technology (with English subtitles)
【BIONET Therapeutics】 AI-Driven, Scalable Exosome Technology (with English subtitles)
意外、車禍受傷怎處理？不留疤、好得快，照護迷思大公開！feat. 中山附醫 陳俊嘉醫師【整形外科專家】
降低關節磨損，破解迷思大公開！feat.曾崇育醫師
【BIONET Therapeutics】AI-Driven, Scalable Exosome Technology (no subtitles)
New Era in Regenerative Medicine |
New Era in Regenerative Medicine
